Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327) [Phase 3]
Phase 3 trial update on an approved drug being studied for a new indication in seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609) [Phase 3]
A Phase 3 trial evaluated the effects of desloratadine and levocetirizine on nasal obstruction in allergic rhinitis. The study (P03609) is r…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365) [Phase 4]
Phase 4 trial update reports on quality of life improvements for asthma and allergic rhinitis patients treated with montelukast (Singulair).
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: MK0476 Study in Adult Patients With Perennial Allergic Rhinitis (0476-397)(COMPLETED) [Phase 3]
Phase 3 trial MK0476 for perennial allergic rhinitis has completed enrollment with status updated to COMPLETED.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366) [Phase 3]
Phase 3 clinical trial update evaluating inflammatory markers in adults with asthma associated with allergic rhinitis who are treated with m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270) [Phase 4]
Phase 4 study assessing intranasal steroids for allergic rhinitis when used alone or in combination with an oral antihistamine; the trial st…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208) [Phase 4]
Phase 4 crossover trial comparing patient preference between unscented Nasonex nasal spray and scented Flonase nasal spray for allergic rhin…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207) [Phase 4]
Phase 4 single-dose crossover study assessing patient preference between unscented Nasonex nasal spray and scented Flonase nasal spray in al…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431) [Phase 4]
Phase 4 clinical trial assessing the onset of effect of mometasone nasal spray in induced allergic rhinitis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378) [Phase 2]
Phase 2 trial MK0476 in adults with allergic rhinitis has completed, according to the clinical trial update.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329) [Phase 4]
A Phase 4 clinical trial comparing montelukast sodium with a comparator in mild to moderate persistent asthma, with coexisting allergic rhin…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) [Phase 3]
A Phase 3 trial evaluating montelukast sodium (MK0476) for asthma and perennial allergic rhinitis symptoms in response to cat exposure has c…
-
FDA approval · 2024-08-14FDA Approved: MOMETASONE FUROATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for mometasone furoate from Glenmark Pharmaceuticals Inc., USA under an ANDA.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis [Phase 4]
Phase 4 trial evaluating nasal provocation tests for diagnosis of house dust mite allergic rhinitis was terminated.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Effect of High Intensity Interval Exercise Training in Patients With Allergic Rhinitis [NA]
The study completed an evaluation of high-intensity interval exercise training in patients with allergic rhinitis, with no pharmaceutical in…
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life
A clinical trial is currently recruiting to study how airway allergic diseases in children and their parents—namely asthma and allergic rhin…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Efficacy of Face Mask in Reducing Respiratory Allergic Symptoms in Birch-allergic Subjects in ALYATEC Exposure Chamber [NA]
A completed clinical trial evaluating whether wearing a face mask reduces respiratory allergic symptoms in birch-allergic subjects within an…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Intratonsillar Immunotherapy for Allergic Rhinitis [NA]
The study NCT06523478 is evaluating intratonsillar immunotherapy for allergic rhinitis and is currently recruiting participants.
-
FDA approval · 2024-07-11FDA Approved: XYZAL ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for XYZAL ALLERGY 24HR (levocetirizine dihydrochloride) filed by Chattem, Inc., related to a sup…
-
FDA label_change · 2024-07-11FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application to add Claritin Chewable Grape and Bubblegum (loratadine) as a chewable formulation from Bayer H…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Validation of Laser Doppler Flowmetry to Identify Allergic Rhinitis Patients With Pharmacogenetic Alterations in Histamine Metabolism
A completed clinical trial validating Laser Doppler Flowmetry as a method to identify allergic rhinitis patients with pharmacogenetic altera…
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: The Role of Filaggrin Mutations and Sensitization Pathways in Allergic Rhinitis and Peanut Allergy
This clinical trial update examines the role of filaggrin gene mutations in sensitization pathways contributing to allergic rhinitis and pea…
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg [Phase 1]
A Phase 1 relative bioavailability study comparing cetirizine HCl gummy 10 mg to cetirizine HCl oral tablets 10 mg, with status not yet recr…
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: House Dust Mite Allergy Trial In Children [Phase 3]
Phase 3 trial in children evaluating a house dust mite allergy treatment has completed and results have been posted. The study focused on al…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat [Phase 3]
Phase 3 study evaluating anti-Fel d 1 antibodies injections for cat-allergic adolescents and adults with allergic rhinitis was terminated, w…